New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
227.81-11.62 (-4.85%)
At close: 04:00PM EDT
232.21 +4.40 (+1.93%)
After hours: 06:15PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
474,624
474,624
486,226
390,982
364,304
Depreciation & amortisation
314,124
314,124
303,870
265,540
234,924
Deferred income taxes
-50,903
-50,903
-35,884
-24,006
-133
Stock-based compensation
72,048
72,048
73,617
71,474
56,341
Change in working capital
-102,380
-102,380
-152,554
42,942
-26,275
Accounts receivable
-
-
-
-
-85,627
Inventory
-62,301
-62,301
-78,523
-25,159
-18,379
Accounts payable
-20,427
-20,427
-2,652
44,901
748
Other working capital
365,370
365,370
294,907
532,027
380,015
Other non-cash items
3,402
3,402
17,973
-31,736
13,612
Net cash provided by operating activities
683,898
683,898
619,640
760,799
546,575
Cash flows from investing activities
Investments in property, plant and equipment
-318,528
-318,528
-324,733
-228,772
-166,560
Acquisitions, net
-194,785
-194,785
-283,392
-1,293,095
-418,628
Purchases of investments
-54,215
-54,215
-158,274
-45,555
-26,692
Sales/maturities of investments
6,667
6,667
4,549
6,532
11,401
Other investing activities
-2,294
-2,294
-9,347
264
-1,065
Net cash used for investing activities
-563,155
-563,155
-607,922
-1,437,932
-601,544
Cash flows from financing activities
Debt repayment
-851,676
-851,676
-2,932,636
-6,281,132
-2,200,400
Common stock repurchased
-24,155
-24,155
-38,651
-40,707
-23,979
Other financing activities
-11,640
-11,640
-48,650
-2,328
-5,947
Net cash used provided by (used for) financing activities
-85,521
-85,521
-42,397
672,598
47,248
Net change in cash
43,266
43,266
-5,100
13,195
-6,927
Cash at beginning of period
241,214
241,214
246,314
233,119
240,046
Cash at end of period
284,480
284,480
241,214
246,314
233,119
Free cash flow
Operating cash flow
683,898
683,898
619,640
760,799
546,575
Capital expenditure
-318,528
-318,528
-324,733
-228,772
-166,560
Free cash flow
365,370
365,370
294,907
532,027
380,015